Pfizer's sales missed estimates for the quarter as the drugmaker tries to transition out of the pandemic. Pfizer chairman and CEO Albert Bourla discusses the path ahead for the company, including its plans for acquisitions. He speaks with Bloomberg Wall Street Week host David Westin.

Utah Governor Spencer Cox Talks Meta Settlement
10:53

Lam Research CEO Tim Archer Talks AI Infrastructure Buildout
06:36

Vanguard & Altruist CEOs Talk Wealth Platform Deal, Prediction Markets
11:55